Literature DB >> 7314325

Volume of polycystic kidneys during reduction of renal function.

H S Thomsen, J K Madsen, J H Thaysen, K Damgaard-Petersen.   

Abstract

Total renal volume was measured by CT scanning in 43 patients with the adult form of polycystic kidney disease whose 24h endogenous creatinine clearance ranged from 8 to 130 ml/min. The total volume of the 2 kidneys increased from 1,212 (SD +/- 411) cm3 in patients with normal renal function to 2,053 (SD +/-698) cm3 in patients with severely decreased function, as compared to 497 (SD +/- 58) cm3 in persons without evidence of renal disease. Despite progression of the disease, the mean difference in size between the 2 kidneys remained constant and was significant only in patients with well-preserved renal function. In 23 of the 43 patients hepatic cysts and in 2 patients pancreatic cysts were demonstrable by CT scanning.

Entities:  

Mesh:

Year:  1981        PMID: 7314325     DOI: 10.1007/bf02927815

Source DB:  PubMed          Journal:  Urol Radiol        ISSN: 0171-1091


  7 in total

Review 1.  Imaging for the prognosis of autosomal dominant polycystic kidney disease.

Authors:  Kyongtae T Bae; Jared J Grantham
Journal:  Nat Rev Nephrol       Date:  2010-02       Impact factor: 28.314

Review 2.  Imaging approaches to patients with polycystic kidney disease.

Authors:  Arlene B Chapman; Wenjing Wei
Journal:  Semin Nephrol       Date:  2011-05       Impact factor: 5.299

Review 3.  The importance of total kidney volume in evaluating progression of polycystic kidney disease.

Authors:  Jared J Grantham; Vicente E Torres
Journal:  Nat Rev Nephrol       Date:  2016-10-03       Impact factor: 28.314

4.  Semiautomated Segmentation of Polycystic Kidneys in T2-Weighted MR Images.

Authors:  Timothy L Kline; Marie E Edwards; Panagiotis Korfiatis; Zeynettin Akkus; Vicente E Torres; Bradley J Erickson
Journal:  AJR Am J Roentgenol       Date:  2016-06-24       Impact factor: 3.959

5.  MRI-based kidney volume measurements in ADPKD: reliability and effect of gadolinium enhancement.

Authors:  Kyongtae T Bae; Cheng Tao; Fang Zhu; James E Bost; Arlene B Chapman; Jared J Grantham; Vicente E Torres; Lisa M Guay-Woodford; Catherine M Meyers; William M Bennett
Journal:  Clin J Am Soc Nephrol       Date:  2009-04-01       Impact factor: 8.237

6.  A comparison of ultrasound and magnetic resonance imaging shows that kidney length predicts chronic kidney disease in autosomal dominant polycystic kidney disease.

Authors:  Harpreet Bhutani; Vikram Smith; Frederic Rahbari-Oskoui; Ankush Mittal; Jared J Grantham; Vicente E Torres; Michal Mrug; Kyongtae T Bae; Zhiyuan Wu; Yinghui Ge; Doug Landslittel; Patrice Gibbs; W Charles O'Neill; Arlene B Chapman
Journal:  Kidney Int       Date:  2015-04-01       Impact factor: 10.612

7.  Clinical proof-of-concept trial to assess the therapeutic effect of sirolimus in patients with autosomal dominant polycystic kidney disease: SUISSE ADPKD study.

Authors:  Andreas L Serra; Andreas D Kistler; Diane Poster; Marian Struker; Rudolf P Wüthrich; Dominik Weishaupt; Frank Tschirch
Journal:  BMC Nephrol       Date:  2007-09-15       Impact factor: 2.388

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.